Impact of FDA recommendations on patient-reported outcome inclusion in ovarian cancer clinical trials
Aviki, E.M., Armbruster, S., Green, A.K., Blinder, V.S.
Published in Gynecologic oncology (01.06.2018)
Published in Gynecologic oncology (01.06.2018)
Get full text
Journal Article
565 The microbial flora of taxane therapy-associated nail disease in cancer patients
Virgen, C.A., Belum, V.R., Kamboj, M., Goldfarb, S.B., Blinder, V.S., Gucalp, A., Lacouture, M.E.
Published in Journal of investigative dermatology (01.05.2017)
Published in Journal of investigative dermatology (01.05.2017)
Get full text
Journal Article
Risk factors for financial toxicity in gynecologic cancer patients receiving treatment
Aviki, E.M., Sokolowski, S., Leitao, M.M., Liebhaber, A., Blinder, V.S., Doyle, S., Johari, S., Chi, A., Esselen, K.M., Broach, V., Brown, C.L., Chi, D.S., Jewell, E., Roche, K. Long, Mueller, J.J., Sonoda, Y., Zivanovic, O., Perchick, W., Gardner, G.J., Abu-Rustum, N.R.
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article